The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat-elevated X-maze

被引:34
作者
Hinks, GL
Brown, P
Field, M
Poat, JA
Hughes, J
机构
[1] Parke-Davis Neurosci. Res. Centre, Addenbrookes Hospital Site, Cambridge CB2 2QB, Hills Road
关键词
anxiety; immediate early gene; elevated X-maze; CCK (cholecystokinin); CI-988; benzodiazepine;
D O I
10.1016/0014-2999(96)00471-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study uses immediate early transcription factor gene expression to map neuronal activation after a single exposure to the elevated X-maze. Exposure to this novel environment leads to widespread upregulation in the gene expression of c-Sos, NGR-A and NGFI-B (the nerve growth factor induced genes), but not c-jun nor jun B as shown by in situ hybridization and northern blot analysis. Changes in c-Sos were evident after just 5 min exposure to the maze. The cholecystokinin, receptor antagonist, CI-988, given intraperitoneally at 1 mg/kg 40 min prior to exposure to the X-maze demonstrated an anxiolytic profile without affecting overall movement around the maze, however it did not reduce the increased levels of gene expression with the methodology used. Likewise the anxiolytic benzodiazepine, chlordiazepoxide at 3 mg/kg did not reduce gene expression. It is concluded that a reduction in an index of behavioural stress/anxiety produced by anxiolytic agents is not concomitantly followed by a detectable reduction in immediate early gene induction.
引用
收藏
页码:153 / 161
页数:9
相关论文
共 39 条
  • [1] ONCOGENE JUN ENCODES A SEQUENCE-SPECIFIC TRANS-ACTIVATOR SIMILAR TO AP-1
    ANGEL, P
    ALLEGRETTO, EA
    OKINO, ST
    HATTORI, K
    BOYLE, WJ
    HUNTER, T
    KARIN, M
    [J]. NATURE, 1988, 332 (6160) : 166 - 171
  • [2] UP-REGULATION OF VASOPRESSIN MESSENGER-RNA IN PARAVENTRICULAR HYPOPHYSIOTROPHIC NEURONS AFTER ACUTE IMMOBILIZATION STRESS
    BARTANUSZ, V
    AUBRY, JM
    JEZOVA, D
    BAFFI, J
    KISS, JZ
    [J]. NEUROENDOCRINOLOGY, 1993, 58 (06) : 625 - 629
  • [3] BECK CHM, 1995, J NEUROSCI, V15, P709
  • [4] THE CHOLECYSTOKININ HYPOTHESIS OF PANIC AND ANXIETY DISORDERS - A REVIEW
    BRADWEJN, J
    KOSZYCKI, D
    DUTERTRE, AC
    BOURIN, M
    PALMOUR, R
    ERVIN, F
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1992, 6 (03) : 345 - 351
  • [5] BRADWEJN J, 1994, CAN J PHYSL PHARM S1, V72, P417
  • [6] THE PERIAQUEDUCTAL GRAY AND DEFENSIVE BEHAVIOR - FUNCTIONAL REPRESENTATION AND NEURONAL ORGANIZATION
    CARRIVE, P
    [J]. BEHAVIOURAL BRAIN RESEARCH, 1993, 58 (1-2) : 27 - 47
  • [7] ANXIOLYTIC EFFECTS OF CCK-B ANTAGONISTS
    COSTALL, B
    DOMENEY, AM
    HUGHES, J
    KELLY, ME
    NAYLOR, RJ
    WOODRUFF, GN
    [J]. NEUROPEPTIDES, 1991, 19 : 65 - 73
  • [8] PATTERN AND TIME-COURSE OF IMMEDIATE-EARLY GENE-EXPRESSION IN RAT-BRAIN FOLLOWING ACUTE STRESS
    CULLINAN, WE
    HERMAN, JP
    BATTAGLIA, DF
    AKIL, H
    WATSON, SJ
    [J]. NEUROSCIENCE, 1995, 64 (02) : 477 - 505
  • [9] CURRAN T, 1987, ONCOGENE, V2, P79
  • [10] CANDIDATE PRODUCT OF THE FBJ MURINE OSTEO-SARCOMA VIRUS ONCOGENE - CHARACTERIZATION OF A 55,000-DALTON PHOSPHOPROTEIN
    CURRAN, T
    TEICH, NM
    [J]. JOURNAL OF VIROLOGY, 1982, 42 (01) : 114 - 122